Catalogue Search | MBRL
Search Results Heading
Explore the vast range of titles available.
MBRLSearchResults
-
DisciplineDiscipline
-
Is Peer ReviewedIs Peer Reviewed
-
Reading LevelReading Level
-
Content TypeContent Type
-
YearFrom:-To:
-
More FiltersMore FiltersItem TypeIs Full-Text AvailableSubjectPublisherSourceDonorLanguagePlace of PublicationContributorsLocation
Done
Filters
Reset
4
result(s) for
"Brawley, Otis Webb"
Sort by:
How we do harm : a doctor breaks ranks about being sick in America
Dr. Brawley exposes the underbelly of healthcare today--the under-treatment of the poor, the over-treatment of the rich, the financial conflicts of interests physicians face, insurance that doesn't demand the best (or even cheapest) care, and a pharmaceutical behemoth concerned with selling drugs, not providing health.
Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening Issues
by
Brawley, Otis Webb
,
Cokkinides, Vilma
,
Smith, Robert A
in
Colorectal cancer
,
Disease control
,
Disease prevention
2008
Each year the American Cancer Society (ACS) publishes a summary of its recommendations for early cancer detection and a summary of the most current data on cancer screening rates and trends in US adults. In 2007, the ACS updated its colorectal cancer screening guidelines in a collaborative effort with the US Multi-Society Task Force and the American College of Radiology. In this issue of the journal, we summarize the current ACS guidelines, provide an update of the most recent data pertaining to participation rates in cancer screening from the Centers for Disease Control and Prevention's Behavioral Risk Factor Surveillance System and the National Health Interview Survey, and address some issues related to access to care. [PUBLICATION ABSTRACT]
Journal Article
Boobs : the war on women's breasts
2020
Investigates the controversy swirling around the breast cancer screening test mammography.
Streaming Video
Prostate Cancer Screening May Do More Harm Than Good
2011
For two decades, some supporters of prostate cancer screening, even some so-called experts, have overstated, exaggerated and, in some cases, misled the public about the evidence supporting its effectiveness. They downplayed or failed to mention the risks of screening and misapplied and misstated basic principles of cancer screening. The Task Force, an independent board of experts in interpretation of medical evidence, convened by the U.S. Agency for Healthcare Research and Quality, sanctioned true screening experts to review and assess every published scientific study concerning prostate cancer screening. This recently published review is very reasonable. It recognizes that the few studies that suggest that prostate screening saves lives are undermined by biases and inconsistencies. Of course, the studies that did not show a benefit to screening also have flaws. However, all studies consistently show that significant harms are associated with screening and the sometimes unnecessary treatment. Ironically, the Task Force recommendation isn't too far apart from that of the American Urologic Association, which represents most of the doctors who diagnose and treat prostate cancer. The association's 2009 publication titled \"PSA Screening Best Practice\" reads: \"Given the uncertainty that PSA testing results in more benefit than harm, a thoughtful and broad approach to PSA is critical. Patients need to be informed of the risks and benefits of testing before it is undertaken. The risks of overdetection and overtreatment should be included in this discussion.\"
Newspaper Article